168 related articles for article (PubMed ID: 7650393)
1. Complement component C5: engineering of a mutant that is specifically cleaved by the C4-specific C1s protease.
Ogata RT; Low PJ
J Immunol; 1995 Sep; 155(5):2642-51. PubMed ID: 7650393
[TBL] [Abstract][Full Text] [Related]
2. Substrate specificities of the protease of mouse serum Ra-reactive factor.
Ogata RT; Low PJ; Kawakami M
J Immunol; 1995 Mar; 154(5):2351-7. PubMed ID: 7868903
[TBL] [Abstract][Full Text] [Related]
3. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
Low PJ; Ai R; Ogata RT
J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
[TBL] [Abstract][Full Text] [Related]
4. Mutants of complement component C3 cleaved by the C4-specific C1-s protease.
Mathias P; Carrillo CJ; Zepf NE; Cooper NR; Ogata RT
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8125-9. PubMed ID: 1518837
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the involvement of arginine 462 and the flanking sequence of human C4 beta-chain in mediating C5 binding to the C4b subcomponent of the classical complement pathway C5 convertase.
Ebanks RO; Isenman DE
J Immunol; 1995 Mar; 154(6):2808-20. PubMed ID: 7876551
[TBL] [Abstract][Full Text] [Related]
6. A 100-kDa protein in the C4-activating component of Ra-reactive factor is a new serine protease having module organization similar to C1r and C1s.
Takayama Y; Takada F; Takahashi A; Kawakami M
J Immunol; 1994 Mar; 152(5):2308-16. PubMed ID: 8133044
[TBL] [Abstract][Full Text] [Related]
7. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.
Ebanks RO; Jaikaran AS; Carroll MC; Anderson MJ; Campbell RD; Isenman DE
J Immunol; 1992 May; 148(9):2803-11. PubMed ID: 1573269
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
9. The structure and function of the first component of complement: genetic engineering approach (a review).
Gál P; Cseh S; Schumaker VN; Závodszky P
Acta Microbiol Immunol Hung; 1994; 41(4):361-80. PubMed ID: 7866721
[TBL] [Abstract][Full Text] [Related]
10. Identification of a catalytic exosite for complement component C4 on the serine protease domain of C1s.
Duncan RC; Mohlin F; Taleski D; Coetzer TH; Huntington JA; Payne RJ; Blom AM; Pike RN; Wijeyewickrema LC
J Immunol; 2012 Sep; 189(5):2365-73. PubMed ID: 22855709
[TBL] [Abstract][Full Text] [Related]
11. Distal recognition site for classical pathway convertase located in the C345C/netrin module of complement component C5.
Sandoval A; Ai R; Ostresh JM; Ogata RT
J Immunol; 2000 Jul; 165(2):1066-73. PubMed ID: 10878385
[TBL] [Abstract][Full Text] [Related]
12. Structural homologies of component C5 of human complement with components C3 and C4 by neutron scattering.
Perkins SJ; Smith KF; Nealis AS; Lachmann PJ; Harrison RA
Biochemistry; 1990 Feb; 29(5):175-80. PubMed ID: 2322569
[TBL] [Abstract][Full Text] [Related]
13. Functional role of the linker between the complement control protein modules of complement protease C1s.
Bally I; Rossi V; Thielens NM; Gaboriaud C; Arlaud GJ
J Immunol; 2005 Oct; 175(7):4536-42. PubMed ID: 16177097
[TBL] [Abstract][Full Text] [Related]
14. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
Giclas PC
J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
[TBL] [Abstract][Full Text] [Related]
15. Murine complement component C4 and sex-limited protein: identification of amino acid residues essential for C4 function.
Ogata RT; Cooper NR; Bradt BM; Mathias P; Picchi MA
Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5575-9. PubMed ID: 2748603
[TBL] [Abstract][Full Text] [Related]
16. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
17. Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2.
Inal JM; Schifferli JA
J Immunol; 2002 May; 168(10):5213-21. PubMed ID: 11994478
[TBL] [Abstract][Full Text] [Related]
18. Third component of trout complement. cDNA cloning and conservation of functional sites.
Lambris JD; Lao Z; Pang J; Alsenz J
J Immunol; 1993 Dec; 151(11):6123-34. PubMed ID: 8245455
[TBL] [Abstract][Full Text] [Related]
19. Substrate specificities of murine C1s.
Ogata RT; Low PJ; Bradt BM; Cooper NR
J Immunol; 1994 Jun; 152(12):5890-5. PubMed ID: 8207214
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of activated C1s, a subcomponent of the first component of human complement, by monoclonal antibodies.
Matsumoto M; Nagaki K
J Immunol; 1986 Nov; 137(9):2907-12. PubMed ID: 2428878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
